Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation
An estimated 75 patients (age 18 years of age or older) will be enrolled from the population
of patients who present for ultrasound-guided radiofrequency ablation (RFA) of CT or
MRI-confirmed multiple primary hepatocellular carcinoma (HCC) or metastatic carcinoma, with
at least one of the tumors being ≤ 1.5 cm in diameter.
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
estimation of the the increase in conspicuity of small intrahepatic tumors with contrast-enhanced sonography
John P. McGahan, M.D.
UC Davis School of Medicine Dept. of Radiology
United States: Institutional Review Board
|UC Davis Medical Center||Sacramento, California 95817|